Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 242

1.

Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases.

Gabathuler R.

Neurobiol Dis. 2010 Jan;37(1):48-57. doi: 10.1016/j.nbd.2009.07.028. Epub 2009 Aug 5. Review.

PMID:
19664710
2.

Getting into the brain: approaches to enhance brain drug delivery.

Patel MM, Goyal BR, Bhadada SV, Bhatt JS, Amin AF.

CNS Drugs. 2009;23(1):35-58. doi: 10.2165/0023210-200923010-00003. Review.

PMID:
19062774
3.

Blood-brain barrier transport of drugs for the treatment of brain diseases.

Gabathuler R.

CNS Neurol Disord Drug Targets. 2009 Jun;8(3):195-204. Review.

PMID:
19601817
4.

Differential receptor-mediated drug targeting to the diseased brain.

Rip J, Schenk GJ, de Boer AG.

Expert Opin Drug Deliv. 2009 Mar;6(3):227-37. doi: 10.1517/17425240902806383. Review.

PMID:
19327042
5.

[New protein vectors for physiological transfer of therapeutic agents to the central nervous system].

Gabathuler R.

Biol Aujourdhui. 2012;206(3):191-203. doi: 10.1051/jbio/2012018. Epub 2012 Nov 22. Review. French.

PMID:
23171842
6.

Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.

Löscher W, Potschka H.

Prog Neurobiol. 2005 May;76(1):22-76. Review.

PMID:
16011870
7.
8.

Drug delivery to brain via the blood-brain barrier.

Scherrmann JM.

Vascul Pharmacol. 2002 Jun;38(6):349-54. Review.

PMID:
12529929
9.

Vector-mediated drug delivery to the brain.

Temsamani J, Rousselle C, Rees AR, Scherrmann JM.

Expert Opin Biol Ther. 2001 Sep;1(5):773-82. Review.

PMID:
11728213
10.
11.

Brain iron homeostasis.

Moos T.

Dan Med Bull. 2002 Nov;49(4):279-301. Review.

PMID:
12553165
12.

The potential for nanoparticle-based drug delivery to the brain: overcoming the blood-brain barrier.

Barbu E, Molnàr E, Tsibouklis J, Górecki DC.

Expert Opin Drug Deliv. 2009 Jun;6(6):553-65. doi: 10.1517/17425240902939143 . Review.

PMID:
19435406
13.

Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2.

Demeule M, Currie JC, Bertrand Y, Ché C, Nguyen T, Régina A, Gabathuler R, Castaigne JP, Béliveau R.

J Neurochem. 2008 Aug;106(4):1534-44. doi: 10.1111/j.1471-4159.2008.05492.x. Epub 2008 May 19.

14.

Current approaches for drug delivery to central nervous system.

Hossain S, Akaike T, Chowdhury EH.

Curr Drug Deliv. 2010 Dec;7(5):389-97. Review.

PMID:
20950269
15.
16.

Assessment of the blood-brain barrier in CNS drug discovery.

Jeffrey P, Summerfield S.

Neurobiol Dis. 2010 Jan;37(1):33-7. doi: 10.1016/j.nbd.2009.07.033. Epub 2009 Aug 5. Review.

PMID:
19664709
17.

Targeting regulation of ABC efflux transporters in brain diseases: a novel therapeutic approach.

Potschka H.

Pharmacol Ther. 2010 Jan;125(1):118-27. doi: 10.1016/j.pharmthera.2009.10.004. Epub 2009 Nov 5. Review.

PMID:
19896502
18.

Chapter 1 - Drug delivery to the brain using colloidal carriers.

Chang J, Jallouli Y, Barras A, Dupont N, Betbeder D.

Prog Brain Res. 2009;180:2-17. doi: 10.1016/S0079-6123(08)80001-5. Epub 2009 Dec 8. Review.

PMID:
20302826
19.

Polymeric nanoparticles for the drug delivery to the central nervous system.

Tosi G, Costantino L, Ruozi B, Forni F, Vandelli MA.

Expert Opin Drug Deliv. 2008 Feb;5(2):155-74. doi: 10.1517/17425247.5.2.155. Review.

PMID:
18248316
20.

Improving brain drug targeting through exploitation of the nose-to-brain route: a physiological and pharmacokinetic perspective.

Badhan RK, Kaur M, Lungare S, Obuobi S.

Curr Drug Deliv. 2014;11(4):458-71. Review.

PMID:
24655046
Items per page

Supplemental Content

Write to the Help Desk